Usage: Aripiprazole Oral Solution is indicated for the treatment of schizophrenia, acute manic and mixed episodes of Bipolar I Disorder, adjunctive treatment of major depressive disorder, irritability associated with autistic disorder, and Tourette’s disorder.
Usage: Asenapine sublingual tablets are indicated for the adjunctive treatment of Bipolar I disorder in adults, specifically in combination with lithium or valproate.
Usage: FANAPT® is indicated for the treatment of schizophrenia in adults and for the acute treatment of manic or mixed episodes associated with bipolar I disorder in adults.
Usage: Fluoxetine capsules are indicated for the treatment of Major Depressive Disorder, Obsessive Compulsive Disorder, Bulimia Nervosa, and Panic Disorder. In combination with Olanzapine, they also treat depressive episodes in Bipolar I Disorder and treatment-resistant depression. Monotherapy with fluoxetine is not approved for Bipolar I or treatment-resistant depression.
Usage: Fluoxetine is indicated for the treatment of Major Depressive Disorder, Obsessive Compulsive Disorder, Bulimia Nervosa, and Panic Disorder. In combination with Olanzapine, it is used for depressive episodes in Bipolar I Disorder and treatment-resistant depression. Monotherapy with fluoxetine is not suitable for these latter conditions.
Usage: Lamotrigine is indicated as adjunctive therapy for partial-onset, primary generalized tonic-clonic, and Lennox-Gastaut syndrome seizures in patients aged 2 and older, and for conversion to monotherapy in adults with partial-onset seizures. It is also used for the maintenance treatment of bipolar I disorder to delay mood episodes.
Usage: Lamotrigine is indicated as adjunctive therapy for partial-onset seizures, primary generalized tonic-clonic seizures, and Lennox-Gastaut syndrome seizures in patients aged 2 and older. It is also used for the maintenance treatment of bipolar I disorder to delay mood episodes, but not for acute episodes.
Usage: Lamotrigine tablets are indicated for adjunctive therapy in epilepsy (partial-onset seizures, primary generalized tonic-clonic seizures, and generalized seizures of Lennox-Gastaut syndrome) in patients aged 2 and older. Additionally, they are used for the maintenance treatment of bipolar I disorder to delay mood episodes.
Usage: Lamotrigine orally disintegrating tablets are indicated for adjunctive therapy in epilepsy, treating partial-onset seizures, primary generalized tonic-clonic seizures, and generalized seizures of Lennox-Gastaut syndrome. They are also used for maintenance treatment of bipolar I disorder to delay mood episode recurrence. Not recommended for acute mood episode treatment.